‘Holy Grail’ – Alterity Therapeutics aims to slow progression of Parkinson’s disease
Alterity Therapeutics is focused on slowing progression of Parkinson’s disease and related disorders Approach of slowing progression considered “Holy Grail” in treatment of neurodegenerative diseases Interim results of a Phase 2 study of lead drug ATH434 …